interconnected chambers containing sensory epithelia (Whitfield, 2015) . Sensory epithelia 48 comprise a salt-and-pepper pattern of sensory hair cells and support cells. Hair cell 49 specification is initiated by expression of the bHLH factor Atonal Homolog 1 (Atoh1) 50 (Bermingham et al., 1999; Chen et al., 2002; Millimaki et al., 2007; Raft et al., 2007; Woods et 51 al., 2004) . Atoh1 subsequently activates expression of Notch ligands that mediate specification 52 of support cells via lateral inhibition. Hair cells are innervated by neurons of the statoacoustic 53 ganglion (SAG), progenitors of which also originate from the otic vesicle. Specification of 54 3 SAG neuroblasts is initiated by localized expression of the bHLH factor Neurogenin1 (Ngn1) 55 (Andermann et al., 2002; Korzh et al., 1998; Ma et al., 1998; Raft et al., 2007) . A subset of 56 SAG neuroblasts delaminate from the otic vesicle to form "transit-amplifying" progenitors that 57 slowly cycle as they migrate to a position between the otic vesicle and hindbrain before 58 completing differentiation and extending processes to hair cells and central targets in the brain 59 (Alsina et al., 2004; Kantarci et al., 2016; Vemaraju et al., 2012) . Zheng et al., 2016) . This is similar to "aerobic glycolysis" (also 91 known as the "Warburg Effect") exhibited by metastatic tumors, thought to be an adaptation for 92 accelerating ATP synthesis while simultaneously producing carbon chains needed for rapid 93 biosynthesis (Liberti and Locasale, 2016) . In addition, aerobic glycolysis and lactate synthesis 94 appears to facilitate cell signaling required for normal development. In a screen to identify novel regulators of SAG development in zebrafish, we recovered two 99 independent mutations that disrupt the glycolytic enzyme Phosphoglycerate Kinase 1 (Pgk1). 100
Loss of Pgk1 causes a delay in upregulation of Fgf signaling in the otic vesicle, causing a 101 deficiency in early neural and sensory development. We show that Pgk1 is co-expressed with 102
Fgf ligands in the otic vesicle, as well as in various clusters of neurons in cranial ganglia and the 103 neural tube. Moreover, Pgk1 acts non-autonomously to promote Fgf signaling at a distance by 104 promoting synthesis and secretion of lactate. Lactate independently activates the MAPK 105 pathway, leading to elevated expression of the effector Etv5b, priming the pathway to render 106 cells more responsive to dynamic changes in Fgf levels. 107 108 5
RESULTS 109

Initial characterization of sagd1 110
To identify novel genes required for SAG development, we conducted an ENU mutagenesis 111 screen for mutations that specifically alter the number or distribution of post-mitotic isl2b:Gfp+ 112 SAG neurons. A recessive lethal mutation termed sagd1 (SAG deficient1) was recovered based 113 on a deficiency in the anterior/vestibular portion of ganglion, which are the first SAG neurons to 114 form. Quantification of isl2b:Gfp+ cells in serial sections of sagd1-/-mutants revealed a ~60% 115 deficiency in anterior/vestibular SAG neurons at 24 and 30 hpf ( Fig. 1A-C ). The number of 116 vestibular neurons remained lower than normal through at least 48 hpf whereas accumulation of 117 posterior/auditory SAG neurons appeared normal ( Fig. 1B) . Staining with anti-Isl1/2 antibody, 118 which labels a more mature subset of SAG neurons, showed a similar trend: There was a 60% 119 deficiency in anterior/vestibular neurons from the earliest stages of SAG development whereas 120 subsequent formation of posterior/auditory neurons was normal (Fig. S1A-I). Of note, the early 121 deficit of SAG neurons did not result from increased apoptosis (Fig. S1J ), and in fact sagd1-/-122 mutants produced fewer apoptotic cells than normal. sagd1-/-mutants show no overt defects in 123 gross morphology, although sagd1-/-mutants do show deficits in balance and motor 124 coordination indicative of vestibular dysfunction. Mutants typically die by 10-12 dpf. To further characterize the sagd1-/-phenotype, we examined earlier stages of SAG 147 development. Specification of SAG neuroblasts is marked by expression of ngn1 in the floor of 148 the otic vesicle, a process that normally begins at 16 hpf, peaks at 24 hpf, and then gradually 149 declines and ceases by 42 hpf (Vemaraju et al., 2012) . We observed that early stages of 150 neuroblast specification were significantly impaired in sagd1-/-mutants, with only 30% of the 151 normal number of ngn1+ neuroblasts at 24 hpf ( Fig. 2A, B , E). However, subsequent stages of 152 specification gradually improved in sagd1-/-mutants, such that the number of ngn1+ neuroblasts 153 in the otic vesicle was normal by 30 hpf (Fig. 2C , D, E). In the next stage of SAG 154 development, a subset of SAG neuroblasts delaminates from the otic vesicle and enters a 155 transit-amplifying phase. Recently delaminated neuroblasts continue to express ngn1 for a 156 8 short time before shifting to expression of neurod, which is then maintained until SAG 157 progenitors mature into post-mitotic neurons. In sagd1-/-mutants, the number of ngn1+ 158 neuroblasts outside the otic vesicle was reduced by 50-60% at every stage examined ( Fig. 2F ). 159
Similarly, the number of neurod+ transit-amplifying cells was strongly reduced in sagd1-/-160 mutants ( Fig. 2G-O) . This deficit was more pronounced at 30 hpf (~60% decrease) than at 48 161 hpf (~20% decrease). Moreover, deficit was restricted to anterior transit-amplifying cells that 162
give rise to vestibular neurons, whereas accumulation of posterior/auditory progenitors was 163 normal (Fig. 2O ). In summary, the neural deficit observed in sagd1-/-mutants reflects a 164 deficiency in early specification of vestibular neuroblasts. In addition, the continuing deficit in 165 anterior transit-amplifying cells at later stages likely contributes to a long-term deficit in 166 vestibular neurons. 
Identification of the sagd1 locus: A novel role for Pgk1 199
To identify the affected locus in sagd1-/-mutants, we used whole genome sequencing and 200 homozygosity mapping approaches (Obholzer et al., 2012) . We identified as our top candidate 201 a novel transcript associated with the gene encoding the glycolytic enzyme Phosphoglycerate 202
Kinase-1 (Pgk1). The zebrafish genome harbors only one pgk1 gene, but the locus produces 2 203 distinct transcripts (Fig. 4A ). The primary transcript (pgk1-FL) encodes full-length Pgk1, which 204 is highly conserved amongst vertebrates (nearly 90% identical between zebrafish and human). 205
However, the second pgk1 transcript, termed pgk1-alt, is unique to zebrafish and arises from an 206 11 independent transcription start site in the first intron of pgk1-FL. There are two short exons 207 (termed exons 1a and 1b) at the start of pgk1-alt that encode a novel peptide with 30 amino 208 acids. pgk1-alt then splices in-frame with exons 2-6, which are identical to pgk1-FL, followed 209 by a splice into a novel exon (termed exon 6a) containing a stop codon ( Fig. 4A ). Thus 210 pgk1-alt encodes a truncated protein that includes much of the N-terminal half of Pgk1 but 211 presumably lacks glycolytic enzyme activity. In sagd1-/-mutants, pgk1-alt contains two 212 nucleotide substitutions leading to loss of a splice acceptor site as well as the translation start 213 codon in exon 1b (Fig. 4B ). Either of these SNPs is predicted to disrupt expression of pgk1-alt 214
protein. 215
Although sagd1 does not alter the sequence of pgk1-FL, we tested whether the sagd1 216 mutation alters accumulation of pgk1-FL transcript. In wild-type embryos pgk1-FL is widely 217 expressed at a low level, but beginning around 18 hpf transcript abundance becomes dramatically 218 accumulation of pgk1-FL was strongly elevated at 24 hpf ( Fig. 4U, V) . This was in contrast to 227 accumulation of transgenic pgk1-alt transcript, which peaked near the end of the heat shock 228 period at 21 hpf (not shown) but then decayed to background levels by 24 hpf (Fig. 4W, X) . 229
We infer that perdurance of Pgk1-alt protein is sufficient to upregulate pgk1-FL. 
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To directly test the requirement for full length Pgk1, we targeted the first exon of pgk1-FL 255 using CRISPR-Cas9 and recovered an indel mutation leading to a frameshift followed by a 256 premature stop (Fig. 4C ). This presumptive null mutation is predicted to eliminate all but the 257 first 19 amino acids of Pgk1. Expression of pgk1 is severely reduced in pgk1-/-mutants, 258
presumably reflecting nonsense-mediated decay (Fig. 4T ). The phenotype of pgk1-/-mutants is 259 identical to sagd1-/-, including reduced otic expression of etv5b at 18 hpf, reduced ngn1 at 24 260 hpf, and deficiencies in neurod+ transit-amplifying cells and mature isl2b-gfp+ SAG neurons 261 ( Fig. 5A-H) . Additionally, development of the trigeminal ganglion and reticulospinal neurons 262 in the hindbrain is also impaired (Fig. 4Y, Z) . When pgk1+/-heterozygotes were crossed with 263 sagd1+/-heterozygotes, all intercross embryos developed normally ( Fig. 5Q ), confirming that 264 pgk1-alt and pgk1-FL encode distinct complementary functions. We also generated a 265 heat-shock inducible transgene to overexpress pgk1-FL (hs:pgk1). Activation of hs:pgk1 at 18 266 hpf rescued the SAG deficiency in sagd1-/-mutants ( Fig. 5Q ). Together, these data show that 267 pgk1-alt is required to locally upregulate pgk1-FL, which in turn is required for proper Fgf 268 signaling and sensory and neural development. The second Pgk1-dependent mechanism employed by metastatic tumors is to upregulate and 317 redirect glycolysis to promote lactate synthesis despite abundant oxygen. This process is often 318 called "aerobic glycolysis", or the "Warburg effect", and is thought to accelerate synthesis of 319 ATP and provide 3-carbon polymers used for rapid biosynthesis (Liberti and Locasale, 2016) . Philp et al., 2005) . We therefore tested 323 whether blocking glycolysis and/or lactate synthesis in wild-type embryos could mimic the 324 16 phenotype of pgk1-/-and sagd1-/-mutants. Treating wild-type embryos with 2-deoxy-glucose 325 (2DG) (Nirenberg and Hogg, 1958) or 3PO (Clem et al., 2008) to block early steps in glycolysis 326 ( Fig. 6A ) reduced the number of mature SAG neurons to a level similar to that of pgk1-/-or 327 sagd1-/-mutants (Fig. 6B) . Similar results were obtained when these inhibitors were added at 0 328 hpf or 14 hpf. 329 330 331 2012) ( Fig. 6A ). Wild-type embryos treated with Galloflavin also displayed a deficiency of 351 SAG neurons similar to pgk1-/-and sagd1-/-mutants ( Fig. 6C ). Finally, to block transport of 352 lactate across the cell membrane, we treated wild-type embryos with either CHC or UK5099, 353 which block activity of monocarboxylate transporters MTC1, 2 and 4 (Halestrap, 1975; 354 Halestrap and Denton, 1974) ( Fig. 6A ). Application of either CHC or UK5099 also mimicked 355 the SAG deficiency in pgk1-/-and sagd1-/-mutants ( Fig. 6C, and data not shown). Treatment 356 of wild-type embryos with 2DG, Galloflavin or CHC also reduced hair cell production to a level 357 comparable to sagd1-/-or pgk1-/-mutants ( Fig. 6D ). To further explore the role of lactate, we 358 added exogenous lactate to embryos beginning at 14 hpf and examined accumulation of SAG 359 neurons at 30 hpf. As shown in Fig. 6C , lactate treatment elevated SAG accumulation above 360 normal in wild-type embryos and fully rescued pgk1-/-mutants. Lactate treatment also rescued 361 hair cell production in wild-type embryos treated with 2DG, Galloflavin, or CHC (Fig. 6D) . 362
Thus, pharmacological agents that block glycolysis, lactate synthesis or lactate secretion are 363 sufficient to mimic the pgk1-/-and sagd1-/-phenotype, and exogenous lactate is sufficient to 364 reverse these effects. 365
We next examined whether the above inhibitors and/or exogenous lactate affect Fgf 366 signaling and SAG specification in the nascent otic vesicle. Treatment of wild-type embryos 367 with Galloflavin or CHC reduced the number of cells expressing etv5b and ngn1 at 18 hpf and 24 368 18 hpf, respectively (Fig. 7Ag , Ah, Bg, Bh, E), mimicking the effects of pgk1-/- (Fig. 7Ab , Bb, C, 369 D). Treatment with exogenous lactate reversed the effects of Galloflavin and CHC (Fig. 7Ai,  370 Aj, Bj) and rescued pgk1-/-mutants ( Fig. Ac, Bc, C, D) . Moreover, treating wild-type embryos 371 with lactate increased the number of cells expressing etv5b and ngn1 (Fig. 7Ae, Be, C, D) . 
385
We also tested whether a deficiency of ATP contributes to the pgk1-/-phenotype. Adding 386 exogenous ATP to pgk1-/-mutants at 14 hpf did not ameliorate the deficiency in expression of 387 etv5b, ngn1, or pax5 (Fig. 7Ad , Bd, C, D; and Fig. S3 ). Likewise, adding ATP to wild-type 388 embryos at 14 hpf did not significantly affect expression of these genes (Fig. 7Af, Bf, C, D; and 389 Fig. S3 ). Finally, adding 25 uM sodium azide to wild-type embryos at 14 hpf to block 390 mitochondrial respiration did not significantly impair expression of ngn1 at 24 hpf (Fig. 7Bk, E) . 391
Thus, lactate is critical for early Fgf signaling and SAG specification, but exogenous ATP does 392 not affect these functions. Moreover, the deficiencies in otic development observed in pgk1-/-393 mutants can be attributed to disruption of lactate synthesis and secretion. 394 reduced the number of ngn1+ cells at 24 hpf (Fig. 7Bl, E) and mature Isl1+ SAG neurons at 30 405 hpf (Fig. S4 ) to a degree similar to or greater than pgk1-/-mutants. In contrast, treatment of 406 wild-type embryos with the PI3K inhibitor LY294002 (Montero et al., 2003) had negligible 407 effects on these genes (Fig. S4, and Fgf receptor from a heat shock-inducible transgene, hs:dnfgfr1, fully suppressed etv5b 419 expression within two hours of heat shock (Fig. 7Ak; Fig. 8C ). Importantly, treatment with 420 exogenous lactate partially restored etv5b expression when Fgf signaling was blocked ( Fig. 7Al ; 421 Fig. 8D ). Because developmental defects in pgk1-/-and sagd1-/-mutants appear to stem from 422
reduced Fgf signaling, we tested whether elevating Fgf can rescue pgk1-/-mutants. Activation 423 of hs:fgf8 at a moderate level (37°C for 30 minutes) beginning at 16 hpf increased the level of 424 pax5 expression in the otic vesicle at 18 hpf and expanded the spatial domain (Fig. 8E, G) . 425 Activation of hs:fgf8 in pgk1-/-mutants increased expression of pax5 relative to pgk1-/-alone 426 ( Fig. 8F, H) , but not to the same degree seen in non-mutant embryos. Thus, elevating either Fgf 427 or lactate alone can partially compensate for loss of the other, but full activation of early otic 428 genes requires both Fgf and lactate. 429 It is interesting that sites of pgk1 upregulation correlate with sites of Fgf ligand expression. 469
Fgf expression does not require pgk1 (Fig. 3S, T) , and pgk1 upregulation does not require Fgf 470 (not shown), suggesting co-regulation by shared upstream factor(s). Analysis of genetic 471 mosaics showed that isolated wild-type cells transplanted into pgk1-/-host embryos failed to 472 activate etv5b despite close proximity to sensory epithelia, a known Fgf-source. Clearly wild 473 type cells retain the ability to perform glycolysis, but since upregulation of pgk1 in the otic 474 vesicle is limited to sensory epithelia and mature SAG neurons ( Fig. 4A-G) , other otic cells may 475 be unable to generate sufficient lactate to augment Fgf signaling. This raises the interesting 476 possibility that Fgf and lactate must be co-secreted from signaling sources to support full 477 signaling potential. 478 Despite the requirement for pgk1-alt in the developing nervous system, it is not required in 501 mesodermal tissues. For example, upregulation of pgk1 in developing somites is not affected in 502 sagd1-/-mutants. Curiously, pgk1 is not appreciably upregulated in presomitic mesoderm, 503 despite the fact that somitogenesis involves a gradient aerobic glycolysis and lactate synthesis 504 that is highest in the tail and declines anteriorly ( Although the sagd1 mutation was recovered in a forward ENU mutagenesis screen, we note 511 that the SNPs detected in the pgk1-alt sequence were previously reported in the genome 512 sequence database. It is therefore likely that familial breeding during our screen allowed 513 generation and detection of homozygous carriers of this preexisting allele. Indeed, we have 514 subsequently detected these SNPs in our wild-type stock, likely accounting for variation in 515 expression levels in early otic genes sometimes detected in specific families. As a cautionary 516 note, the sequence for pgk1-alt was initially represented in older versions of the annotated 517 zebrafish genome but has since been removed, presumably deemed a technical artifact. Had we 518 used more recent versions of the genome as our reference dataset, the SNPs in sagd1 would have 519 been overlooked. Regardless of its origins, identification of the sagd1 mutant allele 520 underscores the continuing utility of forward screens: Had we not recovered sagd1 from our 521 screen, it is highly unlikely that we would have identified pgk1 as a developmental regulatory 522 gene. 
MATERIALS AND METHODS 538
Fish strains and developmental conditions 539
Wild-type embryos were derived from the AB line (Eugene,OR). For most experiments 540 embryos were maintained at 28.5°C, except where noted. Embryos were staged according to 541 standard protocols (Kimmel et al., 1995) . PTU (1-phenyl 2-thiourea), 0.3 mg/ml (Sigma 542 P7629) was included in the fish water to inhibit pigment formation. The following transgenic 543 lines were used in this study: Tg(hsp70:fgf8a) x17 (Millimaki et al., 2010) , 544 
Gene misexpression and morpholino injections 558
Heat-shock regimens were carried in a water bath at indicated temperatures and durations. 559
Embryos were kept in a 33°C incubator after the heat-shock. Transgenic carriers were 560 identified by morphological characteristics. Knockdown of Plasminogen was performed by 561 injecting one-cell stage embryos with ~5 ng of morpholino oligomer with the following 562 sequence: 5'-AACTGCTTTGTGTACCTCCATGTCG-3'. 563 564 26
In situ hybridization and immunohistochemistry 565
Whole mount in situ hybridization and immunohistochemistry protocols used in this study were 566 previously described (Phillips et al., 2001) . Whole mount stained embryos were cut into 10 µm 567 thick sections using a cryostat as previously described (Vemaraju et al., 2012) . The following 568 antibodies were used in this study: Anti-Islet1/2 (Developmental Studies Hybridoma Bank 569 39.4D5, 1:100), Anti-GFP (Invitrogen A11122, 1:250), Alexa 546 goat anti-mouse or anti-rabbit 570 IgG (ThermoFisher Scientific A-11003/A-11010, 1:50). Promega terminal deoxynucleotidyl 571 transferase (M1871) was used according to manufacturer's protocol to perform the TUNEL 572 assay. 573 574
Cell Transplantation 575
Wild-type donor embryos were injected with a lineage tracer (tetramethylrhodamine labeled, 576 10,000 MW, lysine-fixable dextran in 0.2 M KCl) at one-cell stage and transplanted into 577 non-labeled wild-type or pgk1 mutant embryos at the blastula stage. A total of 151 and 247 578 transplanted wild type cells were visualized in the ears of wild-type embryos and pgk1 mutants, 579 respectively, (n= 8 otic vesicles each) and analyzed for the expression of etv5b. 580 581
Pharmacological treatments 582
The pharmacological inhibitors used in this study include Hexokinase inhibitor 2DG 583
(2-Deoxy-Glucose, Sigma D8375), PFKFB3 inhibitor 3PO (Sigma SML1343), Pyruvate 584
Dehydrogenase Kinase inhibitor DCA (dichloroacetate, Sigma 347795), Lactate Dehydrogenase 585 inhibitor Galloflavin (Sigma SML0776), MCT1/2/4 inhibitors CHC 586 (á-cyano-4-hydroxycinnamic acid, Sigma C2020) and UK-5099 (Sigma PZ0160), MEK inhibitor 587 U1026 (Sigma U120) and PI3K inhibitor LY294002 (Sigma L9908). All inhibitors were 588 dissolved in a 10 mm DMSO stock solution and diluted into the final indicated concentrations in 589 fish water. Lactate treatments were performed with a 60% stock sodium DL-lactate solution 590 (Sigma L1375) diluted 1 to 1000 in fish water to a final concentration of 6.7 mM, and buffered 591 27 with 10 mm MES at pH 6.2. Note, lactate treatment has little effect on embryonic development 592 at higher pH (not shown). Treatments were carried in a 24-well plate with a maximum of 15 593 embryos per well in a volume of 500 µl each. 594 595
Statistics 596
Student's t-test was used for pairwise comparisons. Analysis of 3 or more samples was 597 performed by one-way ANOVA and Tukey post-hoc HSD test. Sufficiency of sample sizes 598 was based on estimates of confidence limits. Depending on genotype and probe, 2-8 embryos 599
were utilized for the analysis of gene expression in serial sections; and 7-40 embryos were used 600 for counts of Isl1/2+ SAG neurons or brn3c: GFP+ hair cells in whole mount specimens. 601 602
Whole Genome Sequencing and Mapping Analysis 603
Adult zebrafish males derived from the AB line were mutagenized using the alkylating agent 604 N-ethyl-N-nitrosourea (ENU) and outcrossed to Isl2b: GFP + females as previously described 605 (Riley and Grunwald, 1995) . sagd1 mutants were identified in the screening process due to the 606 decreased expression of Isl2b:Gfp in vestibular SAG neurons. For the mapping analysis, sagd1 607 mutants were outcrossed to the highly polymorphic zebrafish WIK line. A genomic pool of 50 608 homozygous mutants were collected from the intercrosses between 3 pairs of heterozygous 609 sagd1 carriers of the AB/WIK hybrid line and sent for whole genome sequencing at Genomic 610 Sequencing and Analysis Facility (GSAF) at the University of Texas-Austin. Sequence reads 611 were aligned using the BWA alignment software. Bulk segregant linkage and homozygosity 612 mapping of the aligned sequences were performed using Megamapper (Obholzer et al., 2012) . 613
Both approaches identified the pgk1 locus as the top candidate lesion in sagd1 mutants. 614 615
